Miguel Forte

Miguel Forte

President presso International Society For Cell & GeneTherapy

63 anni
Health Technology
Consumer Services
Finance

Profilo

Miguel Forte is currently the Director at Alliance for Regenerative Medicine, Associate Professor at the University of Lisbon and the University of Aveiro, and President-Elect at International Society For Cell & Gene Therapy.
He was previously the Chief Executive Officer & Director at Bone Therapeutics SA, Chief Executive Officer at Zelluna Immunotherapy AS, Medical Director at Bristol Myers Squibb Co., Vice President-Medical Affairs at Union de Crédit Pour le Bâtiment SA, Chief Commercialization Officer at International Society for Cellular Therapy, SVP-Clinical Development & Regulatory Affairs at Sangamo Therapeutics France SAS, Chief Medical Officer at Bone Therapeutics SA, and VP-Clinical, Medical & Regulatory Affairs at Nabi Pharmaceuticals.
He holds a doctorate degree from the University of Birmingham and an undergraduate degree from the University of Lisbon.

Posizioni attive di Miguel Forte

SocietàPosizioneInizio
University of Aveiro Corporate Officer/Principal -
University of Lisbon Corporate Officer/Principal -
Director/Board Member 03/10/2018
International Society For Cell & GeneTherapy President 01/06/2022
Tutte le posizioni attive di Miguel Forte

Precedenti posizioni note di Miguel Forte

SocietàPosizioneFine
Chief Executive Officer 19/12/2019
BIOSENIC SA Chief Tech/Sci/R&D Officer 31/10/2017
BRISTOL-MYERS SQUIBB COMPANY Chief Tech/Sci/R&D Officer 01/01/2003
BIOSENIC SA Chief Executive Officer -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Miguel Forte

Formazione di Miguel Forte

University of Birmingham Doctorate Degree
University of Lisbon Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Miguel Forte

Relazioni

100 +

Relazioni di 1° grado

12

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa1
BRISTOL-MYERS SQUIBB COMPANY

Health Technology

Aziende private8

Finance

Commercial Services

Health Technology

Health Technology

Nabi Pharmaceuticals

Health Services

Health Technology

International Society For Cell & GeneTherapy

Vedi le connessioni aziendali